Which funds bought or sold TECH in Q3 2026?
Bio-Techne Corp. 4 funds bought, 9 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$1.1B.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- Millennium+$225M
- Balyasny+$186M
- QRTNEW+$172M
- D. E. Shaw+$167M
- Fidelity−$848M
- Goldman Sachs−$232M
- Morgan Stanley−$221M
- Capital Research−$122M
- AllianceBernstein−$72M
- Soros FundOUT−$38M
- Royce−$38M
- Brown Advisory−$14M
- Glenview−$2M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (4)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Millennium Quant & multi-strategy | Added+313.7% | +$225M | $297M |
| Balyasny Quant & multi-strategy | Added+306.7% | +$186M | $247M |
| QRT Quant & multi-strategy | New | +$172M | $172M |
| D. E. Shaw Quant & multi-strategy | Added+1008% | +$167M | $183M |
Sold (9)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Fidelity Asset manager | Trimmed-91.5% | −$848M | $79M |
| Goldman Sachs Bank & broker | Trimmed-43.6% | −$232M | $300M |
| Morgan Stanley Bank & broker | Trimmed-47.8% | −$221M | $241M |
| Capital Research Asset manager | Trimmed-64.3% | −$122M | $68M |
| AllianceBernstein Asset manager | Trimmed-49.5% | −$72M | $73M |
| Soros Fund Family office & foundation | Sold out | −$38M | — |
| Royce Value investor | Trimmed-65.6% | −$38M | $20M |
| Brown Advisory Asset manager | Trimmed-15.3% | −$14M | $79M |
| Glenview Hedge fund | Trimmed-38.6% | −$2M | $3M |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.